AstraZeneca expert previews BioBeat21 Summit

BioBeat 21 banner

In advance of the BioBeat21 Summit on 'Transforming medicine development through digital innovation' next month - to be live-streamed from the new AstraZeneca R&D Centre, Cambridge - Cristina Duran, AstraZeneca's Chief Digital Health Officer R&D, shares her thoughts on the digital health space.

Cristina is giving the keynote at the BioBeat21 Summit on 9th November, where an international community of scientists, innovators, entrepreneurs and investors will join together to discuss what the future holds for digital innovation in clinical trials.

BioBeat Founder Miranda Weston-Smith and Catherine Priestley, Head of BioPharmaceuticals R&D Communications, AstraZeneca, spoke to Cristina about the opportunities for improving patient-centered care that lie at the convergence of healthcare and digital technologies.

Read the article here

Find out more and register for BioBeat 21 here


Miranda helps early stage biomedical businesses to attract investment and develop their business strategy. Miranda founded and runs BioBeat, a programme to inspire the next wave of bioentrepreneurs and business leaders

Miranda Weston-Smith